Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Precision Medicine in Acute Myeloid Leukemia Treatment
EP. 1: Genetic Alterations in Acute Myeloid Leukemia
July 22nd 2019
EP. 2: Best Practices for NGS Testing in AML
July 22nd 2019
EP. 3: Therapeutic Approaches Based on Mutations in AML
July 22nd 2019
EP. 4: Prognostic Significance of MRD in AML
July 22nd 2019
EP. 5: MRD Assessment and its Clinical Implications in AML
July 22nd 2019
EP. 6: Treatment Strategies and Patient Specific Factors in AML
July 22nd 2019
EP. 7: Consolidation Strategies in AML
July 22nd 2019
EP. 8: Role of Maintenance Therapy in AML
July 22nd 2019
EP. 9: Treatment of AML With Myelodysplasia-Related Changes
July 22nd 2019
EP. 10: Role of Hypomethylating Agents in AML
July 22nd 2019
EP. 11: Management of Adverse Events in Older Patients With AML
July 22nd 2019
EP. 12: Recent Data on the Treatment of Older Patients With AML
July 22nd 2019
EP. 13: Targeting FLT3 in Patients with Relapsed/Refractory AML
July 22nd 2019
EP. 14: Data Supporting Quizartinib in FLT3+ R/R AML
July 22nd 2019
EP. 15: Relapsed vs. Refractory Data for FLT3 Inhibitors in AML
July 22nd 2019
EP. 16: Targeting IDH1/2 in AML
July 22nd 2019
EP. 17: The Future Treatment Landscape of AML
July 22nd 2019
x